ALPMY
ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (ALPMY)
$74
About ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (ALPMY)
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.
Details
Daily high
$16.19
Daily low
$15.16
Price at open
$15.16
52 Week High
$16.19
52 Week Low
$8.37
Market cap
28.2B
Dividend yield
3.23%
Volume
73,019
Avg. volume
138,957
P/E ratio
13.09
ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. News
Details
Daily high
$16.19
Daily low
$15.16
Price at open
$15.16
52 Week High
$16.19
52 Week Low
$8.37
Market cap
28.2B
Dividend yield
3.23%
Volume
73,019
Avg. volume
138,957
P/E ratio
13.09